Lane H W, Barroso A O, Englert D, Dudrick S J, MacFadyen B S
JPEN J Parenter Enteral Nutr. 1982 Sep-Oct;6(5):426-31. doi: 10.1177/0148607182006005426.
Selenium status was determined on seven patients receiving long-term intravenous hyperalimentation (IVH) and they were followed monthly for 4 to 17 months. Analysis of the IVH solutions for selenium revealed no detectable amounts. The selenium indices measures were (1) erythrocyte selenium levels, (2) erythrocyte glutathione peroxidase activities (GSH-Px), and (3) plasma selenium levels. In general, the IVH population had significantly lower values (p less than 0.001) for these selenium indices than a healthy population (n = 275). The plasma selenium levels decreased to below the normal range within one to two months after initiation of IVH. The below normal ranges varied by patient: three patients by three months, one patient by nine months, and three patients had low and normal values throughout the study. No consistent correlation of individual patient's erythrocyte GSH-Px activities and erythrocyte selenium levels existed, but a positive correlation (r = 0.51, p less than 0.01) occurred between plasma selenium levels and erythrocyte GSH-Px activities. Thus, erythrocyte GSH-Px activities decrease parallel to decreases in plasma selenium levels but not with changes in erythrocyte selenium levels. These data suggest that some of these IVH patients may be at risk for selenium deficiency and that selenium supplementation of IVH solutions may be required. Furthermore, these data suggest that the measurement of erythrocyte GSH-Px activity or selenium levels in some IVH patients may not be related to available body selenium.
对7名接受长期静脉高营养(IVH)的患者进行了硒状态测定,并对他们进行了为期4至17个月的每月随访。对IVH溶液中的硒进行分析,未检测到硒含量。硒指标测量包括:(1)红细胞硒水平,(2)红细胞谷胱甘肽过氧化物酶活性(GSH-Px),以及(3)血浆硒水平。总体而言,这些接受IVH治疗的患者的这些硒指标值显著低于健康人群(n = 275)(p < 0.001)。开始IVH治疗后1至2个月内,血浆硒水平降至正常范围以下。低于正常范围的情况因患者而异:3名患者在3个月时出现,1名患者在9个月时出现,3名患者在整个研究过程中硒水平有低有正常。个体患者的红细胞GSH-Px活性与红细胞硒水平之间不存在一致的相关性,但血浆硒水平与红细胞GSH-Px活性之间存在正相关(r = 0.51,p < 0.01)。因此,红细胞GSH-Px活性的降低与血浆硒水平的降低平行,但与红细胞硒水平的变化无关。这些数据表明,这些接受IVH治疗的患者中的一些人可能有硒缺乏风险,可能需要在IVH溶液中补充硒。此外,这些数据表明,一些接受IVH治疗的患者中红细胞GSH-Px活性或硒水平的测量可能与体内可用硒无关。